Skip to main content
Top
Published in: Brain Tumor Pathology 3/2018

01-07-2018 | Original Article

Histopathological features to define atypical meningioma: What does really matter for prognosis?

Authors: Valeria Barresi, Simona Lionti, Samuel Caliri, Maria Caffo

Published in: Brain Tumor Pathology | Issue 3/2018

Login to get access

Abstract

Atypical meningiomas are diagnosed in the presence of: (1) three or more of the following minor atypical criteria: increased cellularity, small cells with a high nuclear/cytoplasmic ratio, prominent nucleoli, sheeting, and foci of spontaneous or geographic necrosis; (2) mitotic count ≥ 4 mitoses per 10 HPF (high mitotic index); (3) brain invasion. The 5-year disease-free survival (DFS) is around 50%. Due to their heterogeneous behavior, the post-surgical treatment of atypical meningiomas is controversial. This study investigated the ability of histopathological features to predict recurrence risk of atypical meningiomas. Meningiomas classified as atypical only on minor atypical criteria had low recurrence risk. Brain invasion, high mitotic index and sheeting were significantly associated with shorter disease-free survival (DFS) (P = 0.001; P = 0.01; P = 0.01). The presence of brain invasion and the co-presence of sheeting and high mitotic index had the highest ability to identify recurring meningiomas (P = 0.0001) (sensitivity: 90.9%; specificity: 86.7%). Our results suggest reconsideration of classification of meningiomas as atypical based only on minor atypical criteria. The presence of brain invasion and the co-occurrence of sheeting and high mitotic count may be useful to identify high risk cases, which may benefit from adjuvant treatments.
Literature
1.
go back to reference Ostrom QT, Gittleman H, Farah P et al (2013) CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro Oncol suppl 2:ii1–i56 Ostrom QT, Gittleman H, Farah P et al (2013) CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro Oncol suppl 2:ii1–i56
2.
go back to reference Perry A, Louis DN, Budka H et al (2016) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Refeinberger G, von Deimling A (eds) WHO classification of tumours of the central nervous system. IARC press, Lyon, pp 232–245 Perry A, Louis DN, Budka H et al (2016) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Refeinberger G, von Deimling A (eds) WHO classification of tumours of the central nervous system. IARC press, Lyon, pp 232–245
3.
go back to reference Aizer AA, Bi WL, Kandola MS et al (2015) Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer 121:4376–4381CrossRefPubMed Aizer AA, Bi WL, Kandola MS et al (2015) Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer 121:4376–4381CrossRefPubMed
4.
go back to reference Gallagher MJ, Jenkinson MD, Brodbelt AR et al (2016) WHO grade 1 meningioma recurrence: are location and Simpson grade still relevant? Clin Neurol Neurosurg 141:117–121CrossRefPubMed Gallagher MJ, Jenkinson MD, Brodbelt AR et al (2016) WHO grade 1 meningioma recurrence: are location and Simpson grade still relevant? Clin Neurol Neurosurg 141:117–121CrossRefPubMed
5.
go back to reference Perry A, Louis DN, Scheithauer BW et al (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC press, Lyon, pp 164–172 Perry A, Louis DN, Scheithauer BW et al (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC press, Lyon, pp 164–172
6.
go back to reference Perry A, Stafford SL, Scheithauer BW et al (1997) Meningiomas grading: an analysis of histological parameters. Am J Surg Pathol 21:1455–1465CrossRefPubMed Perry A, Stafford SL, Scheithauer BW et al (1997) Meningiomas grading: an analysis of histological parameters. Am J Surg Pathol 21:1455–1465CrossRefPubMed
7.
go back to reference Maier H, Ofner D, Hittmair A, Kitz K, Budka H (1992) Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 77:616–623CrossRefPubMed Maier H, Ofner D, Hittmair A, Kitz K, Budka H (1992) Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 77:616–623CrossRefPubMed
8.
go back to reference Durand A, Labrousse F, Jouvet A et al (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95:367–375CrossRefPubMed Durand A, Labrousse F, Jouvet A et al (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95:367–375CrossRefPubMed
9.
go back to reference Kaur G, Sayegh ET, Larson A et al (2014) Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro Oncol 2014 1:628–636CrossRef Kaur G, Sayegh ET, Larson A et al (2014) Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro Oncol 2014 1:628–636CrossRef
10.
go back to reference Goldbrunner R, Minniti G, Preusser M et al (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17:e383-391CrossRef Goldbrunner R, Minniti G, Preusser M et al (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17:e383-391CrossRef
11.
go back to reference Domingues PH, Sousa P, Otero Á et al (2014) Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype. Neuro Oncol 16:735–747CrossRefPubMedPubMedCentral Domingues PH, Sousa P, Otero Á et al (2014) Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype. Neuro Oncol 16:735–747CrossRefPubMedPubMedCentral
12.
go back to reference Perry A, Brat DJ (2010) Meningiomas. In: Perry A, Brat DJ (eds) Practical surgical neuropathology: a diagnostic approach. Churchill Livingstone Elsevier, Philadelphia Perry A, Brat DJ (2010) Meningiomas. In: Perry A, Brat DJ (eds) Practical surgical neuropathology: a diagnostic approach. Churchill Livingstone Elsevier, Philadelphia
13.
go back to reference De la Monte SM, Flickinger J, Linggood RM (1986) Histopathologic features predicting recurrence of meningiomas following subtotal resection. Am J Surg Pathol 10:836–843CrossRefPubMed De la Monte SM, Flickinger J, Linggood RM (1986) Histopathologic features predicting recurrence of meningiomas following subtotal resection. Am J Surg Pathol 10:836–843CrossRefPubMed
14.
go back to reference Barresi V, Branca G, Granata F et al (2013) Embolized meningiomas: risk of overgrading and neo-angiogenesis. J Neurooncol 113:207–219CrossRefPubMed Barresi V, Branca G, Granata F et al (2013) Embolized meningiomas: risk of overgrading and neo-angiogenesis. J Neurooncol 113:207–219CrossRefPubMed
16.
go back to reference Vranic A, Popovic M, Cör A et al (2010) Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: a study of 86 patients. Neurosurgery 67:1124–1132CrossRefPubMed Vranic A, Popovic M, Cör A et al (2010) Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: a study of 86 patients. Neurosurgery 67:1124–1132CrossRefPubMed
17.
go back to reference Jääskeläinen J, Haltia M, Laasonen E et al (1985) The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol 24:165–172CrossRefPubMed Jääskeläinen J, Haltia M, Laasonen E et al (1985) The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol 24:165–172CrossRefPubMed
18.
go back to reference Barresi V, Caffo M, Branca G et al (2012) Meningeal tumors histologically mimicking meningioma. Pathol Res Pract 208:567–577CrossRefPubMed Barresi V, Caffo M, Branca G et al (2012) Meningeal tumors histologically mimicking meningioma. Pathol Res Pract 208:567–577CrossRefPubMed
19.
go back to reference Barresi V, Caffo M (2017) Rhabdoid meningioma: grading and prognostic significance of this uncommon variant. J Neuropathol Exp Neurol 76:414–416CrossRefPubMed Barresi V, Caffo M (2017) Rhabdoid meningioma: grading and prognostic significance of this uncommon variant. J Neuropathol Exp Neurol 76:414–416CrossRefPubMed
20.
go back to reference Rogers CL, Perry A, Pugh S et al (2016) Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro Oncol 18:565–574CrossRefPubMed Rogers CL, Perry A, Pugh S et al (2016) Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro Oncol 18:565–574CrossRefPubMed
22.
go back to reference Barresi V, Caffo M, Tuccari G (2016) Classification of human meningiomas: lights, shadows, and future perspectives. J Neurosci Res 94:1604–1612CrossRefPubMed Barresi V, Caffo M, Tuccari G (2016) Classification of human meningiomas: lights, shadows, and future perspectives. J Neurosci Res 94:1604–1612CrossRefPubMed
23.
go back to reference Perry A, Scheithauer BW, Stafford SL et al (1999) “Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046–2056PubMed Perry A, Scheithauer BW, Stafford SL et al (1999) “Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046–2056PubMed
24.
go back to reference Kim YJ, Ketter R, Steudel WI et al (2007) Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas. Am J Clin Pathol 128:118–125CrossRefPubMed Kim YJ, Ketter R, Steudel WI et al (2007) Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas. Am J Clin Pathol 128:118–125CrossRefPubMed
25.
go back to reference Pizem J, Velnar T, Prestor B et al (2014) Brain invasion assessability in meningiomas is related to meningioma size and grade, and can be improved by extensive sampling of the surgically removed meningioma specimen. Clin Neuropathol 33:354–363CrossRefPubMed Pizem J, Velnar T, Prestor B et al (2014) Brain invasion assessability in meningiomas is related to meningioma size and grade, and can be improved by extensive sampling of the surgically removed meningioma specimen. Clin Neuropathol 33:354–363CrossRefPubMed
Metadata
Title
Histopathological features to define atypical meningioma: What does really matter for prognosis?
Authors
Valeria Barresi
Simona Lionti
Samuel Caliri
Maria Caffo
Publication date
01-07-2018
Publisher
Springer Singapore
Published in
Brain Tumor Pathology / Issue 3/2018
Print ISSN: 1433-7398
Electronic ISSN: 1861-387X
DOI
https://doi.org/10.1007/s10014-018-0318-z

Other articles of this Issue 3/2018

Brain Tumor Pathology 3/2018 Go to the issue